Dyax

4 results

Dr Clive Dix, who is chief executive of C4X Discovery Holdings, will join the board as a non-executive director

Fledgling Irish treatment company Carrick Therapeutics has announced the appointment of Dr Burt Adelman and Dr Clive Dix to its board. The firm, whic(...)

A combination of Shire and Baxalta would add to the more than $600 billion in healthcare merger deals this year, which has been the busiest in the history of healthcare deal making

Dublin-based drug maker Shire has made a new acquisition offer for peer Baxalta International that is roughly in line with the latter’s valuation expe(...)

Ryanair rose by 3.2 per cent after a strong set of results in the six months to the end of September. Photograph: Andy Rain/EPA

The Iseq rose by 1.1 per cent as European shares had a positive start to the week after business surveys from around the euro zone beat expectations.(...)

Dublin-based Shire has agreed to buy Dyax Corp for about $5.9 billion to gain access to the drug developer’s late-stage experimental treatment for a dangerous inflammatory disease that can block breathing. (Photograph: Simon Dawson/Bloomberg)

Dublin-based Shire has agreed to buy Dyax Corp for about $5.9 billion to gain access to the drug developer’s late-stage experimental treatment for a (...)